# Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension

> **NCT00555880** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 24 (actual)

## Conditions studied

- Hypotension, Orthostatic

## Interventions

- **DRUG:** Midodrine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00555880
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-08
- **Primary completion:** 2005-03-21
- **Final completion:** 2005-03-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555880, "Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00555880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*